Option Care Health, Inc.
OPCH
Rank in Stocks
#3634
Option Care Health, Inc. delivers infusion services to patients in their homes... Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Share Price
$31.21
Last synced: 2026-10-16
Market Cap
$4.67B
Change (1 day)
-0.05%
Change (1 year)
12.37%
Country
US
Trade Option Care Health, Inc. (OPCH)
Category
Healthcare
EPS for Option Care Health, Inc. (OPCH)
EPS as of June 2026 TTM: $1.33
According to Option Care Health, Inc. latest financial reports and stock price the company's current EPS (TTM) is $1.33. At the end of 2023 the company had a EPS of $1.49 an increase over its 2022 EPS that were of $0.83.
EPS history for Option Care Health, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $1.33 | 8.13% |
| 2024 | $1.23 | -17.45% |
| 2023 | $1.49 | 79.52% |
| 2022 | $0.83 | 6.41% |
| 2021 | $0.78 | -1,848.88% |
| 2020 | $-0.04 | -90.90% |
| 2019 | $-0.49 | -69.75% |
| 2018 | $-1.62 | -19.80% |
| 2017 | $-2.02 | 14.12% |
| 2016 | $-1.77 | -89.86% |
| 2015 | $-17.45 | 102.67% |
| 2014 | $-8.61 | 99.31% |
| 2013 | $-4.32 | -193.91% |
| 2012 | $4.60 | 721.43% |
| 2011 | $0.56 | -110.20% |
| 2010 | $-5.49 | -198.74% |
| 2009 | $5.56 | -172.11% |
| 2008 | $-7.71 | -2,241.67% |
| 2007 | $0.36 | -108.76% |
| 2006 | $-4.11 | 47.31% |
| 2005 | $-2.79 | -317.97% |
| 2004 | $1.28 | -21.95% |
| 2003 | $1.64 | -50.60% |
| 2002 | $3.32 | 23.88% |
| 2001 | $2.68 | -844.44% |
| 2000 | $-0.36 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $29.96 | 2,152.63% |
US
|
|
| - | - |
DE
|
|
| $26.12 | 1,863.91% |
US
|
|
| $1.84 | 38.53% |
SA
|
|
| - | - |
MY
|
